Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Advanced Health Intelligence (AHI) specializes in providing health risk assessments derived from digital biomarkers, facilitating proactive risk management for diverse global populations through innovative, easy-to-use smartphone applications. Our digital health assessments offer in-depth evaluations of cardiovascular, metabolic, and mental health risks. With FaceScan, users can obtain health vital estimates in just about two minutes by utilizing camera-sensor inputs on their web or smartphone devices. BodyScan empowers individuals to evaluate their body composition and dimensions, along with the associated health risks, all within the comfort and privacy of their own space. AHI's offerings ensure population risk stratification, enhanced access to preventive resources, contactless and non-invasive risk evaluations, and the ability to self-administer assessments while engaging with remote populations. Our distinctive array of healthcare technologies is protected by patents in numerous countries, highlighting our commitment to innovation in health management. Ultimately, AHI is dedicated to transforming the way people understand and manage their health risks through cutting-edge digital solutions.
Description
By leveraging visual analytics through TIBCO Spotfire®, PerkinElmer Signals Translational offers a comprehensive suite of tools designed to harmonize, manage, search, aggregate, and analyze extensive datasets consistently for translational research, all while ensuring scalability. This platform, driven by TIBCO Spotfire®, supports precision medicine initiatives by providing an unparalleled solution for biomarker discovery and patient stratification. The Linear Mixed Effect App (LME) within Signals Translational empowers researchers to evaluate the influence of various factors on specific phenotypes, allowing for adjustments related to random variables during analysis. Furthermore, it enables the identification of genes significantly affecting cancer stage progression, irrespective of patient origins. Notably, the LME models excel at addressing issues such as missing values and outliers, making them a robust choice for discovering potential biomarkers. Consequently, the integration of these advanced analytics tools enhances the efficacy of translational research in identifying key biomarkers that can lead to more personalized treatment approaches.
API Access
Has API
No
API Access
Has API
No
Integrations
Signals Research Suite
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
No
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
Yes
Mac
Yes
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
Yes
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
No
Vendor Details
Company Name
Advanced Human Imaging
Country
Australia
Website
www.ahi.tech/
Vendor Details
Company Name
PerkinElmer
Founded
1937
Country
United States
Website
perkinelmerinformatics.com/products/clinical-translational/signals-translational/